Corporate Profile
Cell Genesys was founded in 1988 and completed its initial public offering in 1993, trading on the Nasdaq Stock Market under the ticker symbol, CEGE. It is Cell Genesys' policy to fully comply with all rules put forth by the Securities and Exchange Commission (SEC) and the Nasdaq Stock Market. For misplaced stock certificates, please contact our transfer agent directly.
Upcoming and Recent Events | > MORE |
 | Webcast - Replay
Cell Genesys at Rodman & Renshaw Annual Global Investment Conference
11/12/08 at 2:25 p.m. ET |
| Webcast - Replay
Q3 2008 Cell Genesys Earnings Conference Call
11/06/08 at 4:30 p.m. ET |
| Legal Counsel | O'Melveny & Meyers LLP
Menlo Park, CA
|
|  | | INDEPENDANT REGISTERED PUBLIC ACCOUNTING FIRM | Ernst & Young LLP
Palo Alto, CA
|
|
|
| FIRM | ANALYST | PHONE | | Cantor Fitzgerald | Pamela Bassett, D.M.D. | 212.829.4769 | | Needham & Co. | Mark Monane, M.D. | 212.705.0346 | | Rodman and Renshaw | Ren Benjamin, Ph.D. | 212.430.1743 | | Standard & Poor's | Jeffrey Englander | 212.438.2243 |
|
| Cell Genesys is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Cell Genesys's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Cell Genesys or its management. Cell Genesys does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. |
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. |
|
